Tivic Health Systems, Inc.
Support and Resistance Levels
Past performance
News About TIVC
All events for TIVC
All deals for TIVC
Financial Ratios
Financial Statements
TIVC vs Sector & Peers
About Tivic Health Systems, Inc.
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas. Website valionbio.com
Headquarters Fremont, CA, US